Posted in | News

CCT Successfully Performed Test on N-ViroMotive GenSet Locomotive

National Railway Equipment Co. (NREC) today announced that Central California Traction Company (CCT) of Stockton, CA successfully performed an operational test earlier this spring at the Port of Stockton, CA and on its main line of an N-ViroMotive(TM) GenSet locomotive from NREC. The locomotive was a two-engine 1400 HP (2GS-14B) 4-axle unit that is EPA certified and CARB recognized as ultra-low emitting GenSet locomotive. CCT's objective in testing the new locomotive is fuel conservation, protecting the environment and operational efficiency which are vital to CCT's cost effective operations in the Port of Stockton and Stockton to Lodi, CA.

Dave Buccolo, CCT General Manager, said, “The CCT found that the locomotive’s adhesion was very impressive. It consistently pulled very well, pulling the same tonnage as two of CCT’s SW 1500 units up a 2% grade. And when CCT analyzed the fuel consumption, there was a 61% fuel saving per 8 hour shift compared to one of CCT’s SW 1500s.” Gen-Set locomotives will help the CCT and the Port of Stockton make reductions in emissions in the San Joaquin Valley and at the Port of Stockton.

Jim Wurtz, NREC’s vice president marketing and sales, said, “Already proven in service, these efficient GenSet locomotives are years ahead of anticipated EPA emissions regulations for new switching locomotives.”

The operational advantages the N-ViroMotive locomotives are dramatic:

  • 80%+ reduction in nitrous oxide (NOx) and particulate matter (PM) emissions
  • 50% to 65%+ improved in tractive effort adhesion efficiency
  • Up to 60% fuel savings capability in switching and road switching service
  • Microprocessor-based electronic controls and modularized mechanical platforms significantly decrease maintenance requirements
  • Quiet operation that easily achieves the most stringent noise level requirements for off-road capital equipment

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.